From Research to Real-World Impact: How Computing Is Transforming Healthcare RDI in Saudi Arabia

  • Homepage
  • Event
  • From Research to Real-World Impact: How Computing Is Transforming Healthcare RDI in Saudi Arabia
Prof. Selwa Al-Hazzaa

Prof. Selwa Al-Hazzaa

Chairman of the Board and Founder, SDM Distinguished Professor and Senior Consultant of Ophthalmology Senior Advisor to the President, King Abdulaziz City for Science and Technology (KACST) Former Member, Saudi Shura Council
Tuesday, 27 October 2026 11:00 – 11:45 AM
Building 19, Hall 1
Keynote
02 Session Talk 02 Health and Wellness
Presentation

Abstract

From Research to Real-World Impact: How Computing Is Transforming Healthcare RDI in Saudi Arabia

Saudi Arabia’s healthcare challenge is one of scale, & scale is where high-performance computing & artificial intelligence become decisive. According to the International Diabetes Federation, 589 million people live with diabetes worldwide. The MENA region is projected to grow from 84.7 million people with diabetes in 2024 to 162.6 million by 2050. In the Kingdom, adults with diabetes increased from 4.12 million in 2021 to 5.81 million in 2024, while diabetic eye disease screening coverage stands at 55%. Specialist-led screening cannot close this gap, so automation is essential.

SAARIA shows how national computing capacity becomes clinical capability. Its models were trained on 100,000 retinal images (both Saudi & open-source datasets), using more than 30,000 GPU-hours on KAUST’s Ibex supercomputing platform, & further models are in training. The result holds the first SFDA Medical Device Marketing Authorization in the GCC for AI diagnosis of diabetic retinopathy. A pathway that once took weeks or months, with referral, dilation & specialist review, becomes a single visit. One non-dilated image is taken per eye, graded to the ICDR international standard, & returned as a bilingual Arabic–English report in about one minute. The system showed sensitivity above 90% in clinical validation & needs no specialist on site. Patient data are hosted in-Kingdom under the Personal Data Protection Law, which shows that sovereign AI depends on sovereign infrastructure. Deployment is designed to bring care directly to patients, in hospitals, diabetes centers, primary care, pharmacies & optical shops. The first Saudi billing code for AI retinal diagnosis, introduced by SDM to the Council of Health Insurance, creates a route from innovation to routine care.

Computing also makes the platform extensible. The same image & the same camera & a growing list of diseases with new modules. Glaucoma & hypertension are in final fine-tuning, cardiovascular disease is in development, & Alzheimer’s disease is in research. This marks a shift from diagnosis to prediction, & prediction carries greater ethical weight.

The same approach extends to other clinical areas as:

  • SAMIA to be trained on 60,000 mammogram images supporting radiologists in early breast-cancer detection in a country with one radiologist per 7,000 people.
  • MUNIR applies AI to clinical documentation & patient follow-up.
  • Edge AI, explored with SAIL & Qualcomm, moves computation from the cloud to the point of care. This strengthens privacy & extends reach into underserved settings, though edge deployment is not ethical by default.

AI now diagnoses, predicts, documents & supports decisions, but the physician remains the final authority. AI can support the decision; it cannot inherit the responsibility. The ethical contract of healthcare AI rests on trust, the sanctity of health data, & human accountability. The Kingdom’s advantage lies in combining world-class computing with regulatory rigor, data sovereignty & clinical leadership. International models can be imported; approvals, sovereignty & clinical standing cannot.

About the speaker

Biography

Professor Selwa Al-Hazzaa is a pioneering Saudi physician, scientist, academic, and technology entrepreneur recognized for her contributions to ophthalmology, artificial intelligence, healthcare innovation, and women’s empowerment in Saudi Arabia.

In 2019, she founded SDM after earning an MS in Medical Management and Artificial Intelligence from the University of Southern California. Under her leadership, SDM became the first company in the region to utilize advanced automated retinal image analysis for the early diagnosis of chronic diseases through AI-driven healthcare solutions. The company has been supported by leading Saudi innovation entities, including MCIT, KACST, The Garage, KAUST, Saudi FDA, NTDP, SNIH, and RDIA.

Professor Al-Hazzaa has played a historic role in advancing women’s leadership in Saudi Arabia. She was the only female physician to serve as attending ophthalmologist to the late King Fahad bin Abdulaziz Al Saud. In 2013, by Royal Decree, she became one of the first women appointed to the Saudi Shura Council.

Her international career includes serving as an Executive Member of the International Council of Ophthalmology and as Senior Advisor to the Saudi Minister of Health and the President of KACST. Academically, she has held distinguished appointments at Johns Hopkins University, the University of Southern California, King Abdulaziz University, and Alfaisal University.

Her honors include recognition by Forbes among “The Most Powerful Arab Women” in 2005 and the 2024 Amazon Women in Tech “Most Influential Woman” award. In 2026, she received the Gold Medal with Distinction and Congratulations of the Jury at the International Exhibition of Inventions Geneva, along with a special award from Taiwan recognizing the scientific and applied value of her innovation.

Professor Al-Hazzaa continues to advance AI-driven healthcare, equitable access to innovative diagnostic solutions, women’s leadership, scientific research, and academic excellence in Saudi Arabia and internationally.

Attend this session

The Saudi HPC/AI Conference runs 26–28 October 2026 at KAUST. Attendance is free, but registration is required.